Plant-Based Meal Replacements for Weight Loss and Diabetes Remission
Meal Replacement
Body Weight+8
+ Body Weight Changes
+ Diabetes Mellitus
Treatment Study
Summary
Study start date: September 1, 2025
Actual date on which the first participant was enrolled.This clinical trial is exploring the use of plant-based meal replacement products to help people lose weight and potentially improve conditions like diabetes. It specifically targets individuals participating in the Wellness Institute's Weight Loss Clinic program. The study aims to see if these meal replacements can fit into the existing program, help people lose weight, and lead to better lifestyle habits and reduced risks for chronic diseases, including the potential remission of diabetes and pre-diabetes. This research is important as it could offer a new, plant-based option for people struggling with weight management and related health issues. Participants in this study will follow their weight loss program for 16 weeks. Those in the intervention group will use the meal replacements, choosing daily between a bar or a shake and recording their choices. The study compares the results of participants using the meal replacements to those who do not, focusing on changes in weight, lifestyle behaviors, and health markers. There is no specific mention of risks, but the goal is to see if incorporating these meal replacements is a practical and beneficial addition to weight loss strategies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Seven Oaks Hospital Chronic Disease Innovation Centre
Winnipeg, CanadaOpen Seven Oaks Hospital Chronic Disease Innovation Centre in Google Maps